|
AU2004251668A1
|
|
5-membered heterocycle-based p-38 inhibitors
|
|
CA2559711A1
|
|
Nuclear magnetic resonance assembly of chemical entities using advanced antenna probes
|
|
AU2003247397A8
|
|
Common ligand universal enzyme and compositions for use therein
|
|
AU2003230727A8
|
|
Common ligand mimics: naphtoates
|
|
AU2003218327A8
|
|
Identification of ligands for a receptor family and related methods
|
|
AU2003215351A1
|
|
Common ligand mimics: thiazolidinediones and rhodanines
|
|
WO03023392A1
|
|
Nuclear magnetic resonance assembly of chemical entities
|
|
AU2002312146A1
|
|
Nuclear magnetic resonance-docking of compounds
|
|
EP1354207A2
|
|
Prediction of functional and structural properties of polypeptides
|
|
US6792355B2
|
|
Methods for determining polypeptide structure, function or pharmacophore from comparison of polypeptide sequences
|
|
AU5655602A
|
|
Sea-trosy and related methods
|
|
WO02056236A2
|
|
Classification of polypeptides by ligand geometry and related methods
|
|
WO0075364A2
|
|
Nmr rapid identification of bi-ligand drug candidates
|
|
EP1080369A1
|
|
Multi-partite ligands and methods of identifying and using same
|
